Birdwatch Note
2023-11-20 12:43:41 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
デマです。 第一三共株式会社は治験薬投与4週間後の血中抗SARS-CoV-2(オミクロ ン株BA.5)中和活性の幾何平均抗体価及び免疫応答率は、対照薬(国内既承COVID-19オミクロン株対応2価ワクチン)群と比較して高い値を示し、統計学的に非劣性であることが検証された。 また、安全性では、臨床上の懸念は認められなかったとコメントしています。 https://www.daiichisankyo.co.jp/files/news/pressrelease/pdf/202309/20230906_J.pdf 科学的根拠の無い虚偽の風説を流布し、その業務を妨害した際には、信用毀損および偽計業務妨害罪が成立し罪に問われる場合があるので注意してください。 https://kusatsu.vbest.jp/columns/criminal/g_other/3658/
Written by DE046CA89824342596338C9BEE862F6A98B9155DFA6310F6F25D3E5F02188A96
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1726359695408140651
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1726582082976313494
- noteId - 1726582082976313494
- participantId -
- noteAuthorParticipantId - DE046CA89824342596338C9BEE862F6A98B9155DFA6310F6F25D3E5F02188A96 Participant Details
- createdAtMillis - 1700484221581
- tweetId - 1726359695408140651
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- デマです。 第一三共株式会社は治験薬投与4週間後の血中抗SARS-CoV-2(オミクロ ン株BA.5)中和活性の幾何平均抗体価及び免疫応答率は、対照薬(国内既承COVID-19オミクロン株対応2価ワクチン)群と比較して高い値を示し、統計学的に非劣性であることが検証された。 また、安全性では、臨床上の懸念は認められなかったとコメントしています。 https://www.daiichisankyo.co.jp/files/news/pressrelease/pdf/202309/20230906_J.pdf 科学的根拠の無い虚偽の風説を流布し、その業務を妨害した際には、信用毀損および偽計業務妨害罪が成立し罪に問われる場合があるので注意してください。 https://kusatsu.vbest.jp/columns/criminal/g_other/3658/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-11-20 12:43:41 UTC (1700484221581) |
1969-12-31 23:59:59 UTC (-1) |
2023-11-21 04:11:11 UTC (1700539871995) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-11-20 16:31:23 -0600 | Rating Details | |
2023-11-20 16:23:47 -0600 | Rating Details | |
2023-11-20 14:27:15 -0600 | Rating Details | |
2023-11-20 10:37:22 -0600 | Rating Details | |
2023-11-20 09:55:45 -0600 | Rating Details | |
2023-11-20 09:15:28 -0600 | Rating Details | |
2023-11-20 09:01:37 -0600 | Rating Details | |
2023-11-20 08:57:57 -0600 | Rating Details | |
2023-11-20 08:57:38 -0600 | Rating Details | |
2023-11-20 08:35:42 -0600 | Rating Details | |
2023-11-20 08:30:12 -0600 | Rating Details | |
2023-11-20 08:29:12 -0600 | Rating Details | |
2023-11-20 08:26:03 -0600 | Rating Details | |
2023-11-20 08:22:11 -0600 | Rating Details | |
2023-11-20 08:20:26 -0600 | Rating Details | |
2023-11-20 08:01:26 -0600 | Rating Details | |
2023-11-20 07:58:13 -0600 | Rating Details | |
2023-11-20 07:56:56 -0600 | Rating Details | |
2023-11-20 07:51:40 -0600 | Rating Details | |
2023-11-20 07:49:40 -0600 | Rating Details | |
2023-11-20 07:46:41 -0600 | Rating Details | |
2023-11-20 07:46:17 -0600 | Rating Details | |
2023-11-20 07:44:04 -0600 | Rating Details | |
2023-11-20 07:40:45 -0600 | Rating Details | |
2023-11-20 07:38:25 -0600 | Rating Details | |
2023-11-20 07:36:06 -0600 | Rating Details | |
2023-11-20 07:35:42 -0600 | Rating Details | |
2023-11-20 07:35:11 -0600 | Rating Details | |
2023-11-20 07:29:45 -0600 | Rating Details | |
2023-11-20 07:25:36 -0600 | Rating Details | |
2023-11-20 07:21:05 -0600 | Rating Details | |
2023-11-20 07:10:48 -0600 | Rating Details | |
2023-11-20 06:50:02 -0600 | Rating Details | |
2023-11-21 09:10:57 -0600 | Rating Details | |
2023-11-20 20:17:28 -0600 | Rating Details | |
2023-11-28 04:54:01 -0600 | Rating Details | |
2023-11-22 19:00:26 -0600 | Rating Details | |
2023-11-21 09:14:52 -0600 | Rating Details | |
2023-11-21 00:44:47 -0600 | Rating Details | |
2023-11-20 23:13:09 -0600 | Rating Details | |
2023-11-20 21:03:09 -0600 | Rating Details | |
2023-11-20 19:07:48 -0600 | Rating Details | |
2023-11-20 17:49:21 -0600 | Rating Details | |
2023-11-20 16:37:27 -0600 | Rating Details | |
2023-11-20 15:56:54 -0600 | Rating Details | |
2023-11-20 15:26:46 -0600 | Rating Details | |
2023-11-20 15:13:18 -0600 | Rating Details | |
2023-11-20 14:03:24 -0600 | Rating Details | |
2023-11-20 13:26:15 -0600 | Rating Details | |
2023-11-20 13:18:16 -0600 | Rating Details | |
2023-11-20 11:56:47 -0600 | Rating Details | |
2023-11-20 11:38:10 -0600 | Rating Details | |
2023-11-20 10:13:06 -0600 | Rating Details | |
2023-11-20 09:29:20 -0600 | Rating Details | |
2023-11-20 08:13:58 -0600 | Rating Details | |
2023-11-20 07:54:00 -0600 | Rating Details | |
2023-11-20 07:53:34 -0600 | Rating Details | |
2023-11-20 07:52:51 -0600 | Rating Details | |
2023-11-20 07:45:15 -0600 | Rating Details | |
2023-11-20 07:32:17 -0600 | Rating Details | |
2023-11-20 07:25:07 -0600 | Rating Details | |
2023-11-20 07:24:52 -0600 | Rating Details | |
2023-11-20 07:21:33 -0600 | Rating Details | |
2023-11-20 07:20:07 -0600 | Rating Details | |
2023-11-20 07:11:42 -0600 | Rating Details | |
2023-11-20 07:05:34 -0600 | Rating Details | |
2023-12-02 17:27:15 -0600 | Rating Details |